RDY 291 (Sumatriptan 25 mg)

Pill imprint RDY 291 has been identified as Sumatriptan succinate 25 mg.

Sumatriptan is used in the treatment of cluster headaches; migraine; new daily persistent headache; cyclic vomiting syndrome and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Sumatriptan 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for RDY 291

Sumatriptan succinate 25 mg RDY 291
Sumatriptan succinate
Imprint:
RDY
291
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0291
Inactive Ingredients:
croscarmellose sodium
lactose anhydrous
lactose monohydrate
magnesium stearate
mannitol
microcrystalline cellulose
magnesium silicate
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)